Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) saw some unusual options trading on Tuesday. Investors acquired 26,725 call options on the stock. This represents an increase of approximately 81% compared to the typical volume of 14,793 call options.

Wall Street Analyst Weigh In

TDOC has been the subject of several analyst reports. Stifel Nicolaus decreased their price objective on Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a report on Thursday, February 26th. Barclays cut their target price on shares of Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a research note on Thursday, March 26th. Leerink Partners cut their target price on shares of Teladoc Health from $8.50 to $5.50 and set a “market perform” rating for the company in a research note on Thursday, February 26th. BMO Capital Markets cut their target price on shares of Teladoc Health from $8.00 to $5.00 and set a “market perform” rating for the company in a research note on Thursday, February 26th. Finally, Citigroup raised their target price on shares of Teladoc Health from $6.00 to $7.00 and gave the company a “neutral” rating in a research note on Tuesday, May 5th. Five research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $7.53.

Teladoc Health Price Performance

NYSE:TDOC traded up $0.30 during mid-day trading on Tuesday, reaching $6.65. The stock had a trading volume of 1,912,227 shares, compared to its average volume of 5,878,010. The stock has a 50-day simple moving average of $5.75 and a two-hundred day simple moving average of $6.29. The stock has a market capitalization of $1.20 billion, a PE ratio of -6.83 and a beta of 2.08. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.80 and a quick ratio of 2.72. Teladoc Health has a 12 month low of $4.40 and a 12 month high of $9.77.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). The firm had revenue of $613.85 million during the quarter, compared to the consensus estimate of $611.04 million. Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The business’s revenue was down 2.5% compared to the same quarter last year. During the same period last year, the business earned ($0.53) earnings per share. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. On average, equities analysts anticipate that Teladoc Health will post -0.92 earnings per share for the current year.

Insider Buying and Selling at Teladoc Health

In other news, CEO Charles Divita III sold 27,731 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $5.49, for a total value of $152,243.19. Following the completion of the transaction, the chief executive officer owned 364,784 shares in the company, valued at $2,002,664.16. This trade represents a 7.06% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.70% of the stock is owned by insiders.

Hedge Funds Weigh In On Teladoc Health

Several large investors have recently bought and sold shares of the company. Janus Henderson Group PLC grew its stake in shares of Teladoc Health by 7.7% in the first quarter. Janus Henderson Group PLC now owns 262,215 shares of the health services provider’s stock worth $1,429,000 after purchasing an additional 18,679 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in Teladoc Health by 694.5% in the 1st quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock worth $31,000 after purchasing an additional 4,945 shares in the last quarter. California State Teachers Retirement System grew its position in Teladoc Health by 61.2% in the 1st quarter. California State Teachers Retirement System now owns 274,441 shares of the health services provider’s stock worth $1,496,000 after purchasing an additional 104,160 shares in the last quarter. Quantinno Capital Management LP grew its position in Teladoc Health by 128.0% in the 1st quarter. Quantinno Capital Management LP now owns 2,621,378 shares of the health services provider’s stock worth $14,287,000 after purchasing an additional 1,471,631 shares in the last quarter. Finally, SummitTX Capital L.P. bought a new stake in Teladoc Health in the 1st quarter worth about $339,000. 76.82% of the stock is currently owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.